Fall Clinical 2025 News: Roflumilast Cream Improves Sleep in AD Patients and Their Family Members
Roflumilast cream 0.15% and 0.05% (Zoryve, Arcutis Biotherapeutics, Inc.) improves quality of life by helping reduce sleep disruptions and provides long-term, durable disease control for people with atopic dermatitis (AD) aged 2 years and up.